TigerOak Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
TigerOak Management's IBRX Position: Q3 2026 in Review
TigerOak Management held its ImmunityBio (IBRX) position steady in Q3 2026 at 72,368 shares worth $683K. The position accounts for 0.18% of the portfolio, ranked #70.
TigerOak Management first reported a position in IBRX in Q4 2025 and has held it in 4 quarters since. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- TigerOak Management held 72,368 shares of ImmunityBio worth $683K as of Q3 2026.
- TigerOak Management left its ImmunityBio share count unchanged in Q3 2026.
- ImmunityBio made up 0.18% of TigerOak Management's portfolio in Q3 2026, its #70 holding.
- TigerOak Management first reported a position in ImmunityBio in Q4 2025 and has held it in 4 quarters since.
- 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on TigerOak Management's 13F filing for Q3 2026, filed 23 Oct 2026.